首页|体外膜肺氧合在急性心肌梗死合并心源性休克患者中的应用研究进展

体外膜肺氧合在急性心肌梗死合并心源性休克患者中的应用研究进展

扫码查看
心源性休克(CS)是急性心肌梗死(AMI)常见的并发症,也是AMI患者死亡率增高的重要原因。体外膜肺氧合(ECMO)能提供持续、有效的呼吸循环支持,可稳定患者血流动力学,减轻组织低灌注造成的全身器官功能损害,为AMI合并CS患者心功能恢复赢得时间,在AMI合并CS治疗中凸显出重要价值。不过ECMO技术复杂,临床管理难度较大,现就ECMO在AMI合并CS患者中的应用研究进展进行综述,为临床AMI合并CS治疗及ECMO技术开展提供相关参考。
Application of ECMO in Patients with AMI Complicated with Cardiogenic Shock
Cardiogenic shock(CS)is a common complication of acute myocardial infarction(AMI)and an important cause of increased mortality in patients with AMI.Extracorporeal membrane oxygenation(ECMO)can provide continuous and effective respiratory circulation support,stabilize hemodynamics of patients,reduce systemic organ function damage caused by tissue hypoperfusion,and gain time for cardiac function recovery in patients with AMI complicated with CS.ECMO highlights its important value in the treatment of AMI with CS.However,ECMO technology is complex and the clinical management is difficult.This paper reviews the research progress on application of ECMO in patients with AMI complicated with CS,so as to provide relevant reference for the clinical treatment of AMI with CS and the development of ECMO technology.

Extracorporeal membrane oxygenationAcute myocardial infarctionCardiogenic shockRespiratory circulation support

艾婷婷、刘思捷、蔡珍

展开 >

四川大学华西医院心脏内科,四川 成都 610041

体外膜肺氧合 急性心肌梗死 心源性休克 呼吸循环支持

四川省卫生健康委员会科研课题

20PJ045

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(1)
  • 38